Corentin Lasseaux

Title: Corentin Lasseaux: Innovator in Monocytopoiesis Modulation

Introduction

Corentin Lasseaux is a notable inventor based in Lille, France. He has made significant contributions to the field of hematology, particularly in the modulation of monocytopoiesis. His innovative work has implications for understanding and treating inflammatory responses in the body.

Latest Patents

Corentin Lasseaux holds a patent titled "Methods and pharmaceutical compositions for modulating monocytopoiesis." This patent addresses the hematological process that supplies the periphery with monocytes, which subsequently develop into macrophages and monocyte-derived dendritic cells. The patent highlights the role of type I interferons in promoting the differentiation of monocyte-derived phagocytes at their progenitor level. Notably, it was discovered that IFN-alpha and -beta effectively generate monocyte-derived antigen-presenting cells without affecting the precursor activity of conventional dendritic cells. This research indicates that modulators of type I interferon, such as neutralizing antibodies or type I IFN polypeptides, could be beneficial for individuals needing monocytopoiesis modulation.

Career Highlights

Throughout his career, Corentin Lasseaux has worked with esteemed institutions, including the Institut National de la Santé et de la Recherche Médicale and the Institut Pasteur de Lille. His research has contributed to advancements in understanding the immune system and its responses.

Collaborations

Corentin has collaborated with notable colleagues, including Lionel Poulin and Mathias Chamaillard. These partnerships have further enriched his research and innovation in the field.

Conclusion

Corentin Lasseaux is a pioneering inventor whose work in monocytopoiesis modulation is paving the way for new therapeutic approaches in immunology. His contributions are vital for advancing our understanding of the immune response and developing effective treatments.